BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 17873601)

  • 21. [Genetics, pain and analgesia].
    Stamer U; Bayerer B; Stüber F
    Anaesthesist; 2006 Jul; 55(7):746-52. PubMed ID: 16625360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of opioid pharmacogenetics.
    Argoff CE
    Clin J Pain; 2010 Jan; 26 Suppl 10():S16-20. PubMed ID: 20026961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of genetic variants to pain susceptibility in Parkinson disease.
    Greenbaum L; Tegeder I; Barhum Y; Melamed E; Roditi Y; Djaldetti R
    Eur J Pain; 2012 Oct; 16(9):1243-50. PubMed ID: 22473870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Individual differences in analgesic effects of narcotics].
    Ide S; Kasai S; Ikeda K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):43-8. PubMed ID: 18411709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid genetics in the context of opioid switching.
    Droney J; Riley J; Ross J
    Curr Opin Support Palliat Care; 2012 Mar; 6(1):10-6. PubMed ID: 22228031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [How can we cope with wide individual variations in pain intensity and opioid requirements after surgery?].
    Hayashida M; Maruyama K
    Masui; 2009 Sep; 58(9):1086-92. PubMed ID: 19764430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacogenetics of codeine hypoalgesia.
    Sindrup SH; Brøsen K
    Pharmacogenetics; 1995 Dec; 5(6):335-46. PubMed ID: 8845855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms and human sensitivity to opioid analgesics.
    Nishizawa D; Hayashida M; Nagashima M; Koga H; Ikeda K
    Methods Mol Biol; 2010; 617():395-420. PubMed ID: 20336437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
    Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D
    Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: interactions between genotype and response to therapy in inflammatory bowel diseases.
    Herrlinger KR; Jewell DP
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1403-12. PubMed ID: 17081161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*.
    Huang CJ; Liu HF; Su NY; Hsu YW; Yang CH; Chen CC; Tsai PS
    Anaesthesia; 2008 Dec; 63(12):1288-95. PubMed ID: 19032295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetics of Postoperative Pain Management: A Review.
    Aroke EN; Kittelsrud JM
    AANA J; 2020 Jun; 88(3):229-236. PubMed ID: 32442101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.
    Shao L; Hewitt M; Jerussi TP; Wu F; Malcolm S; Grover P; Fang K; Koch P; Senanayake C; Bhongle N; Ribe S; Bakale R; Currie M
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1674-80. PubMed ID: 18242987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro interaction of codeine and diclofenac.
    Ammon S; von Richter O; Hofmann U; Thon KP; Eichelbaum M; Mikus G
    Drug Metab Dispos; 2000 Oct; 28(10):1149-52. PubMed ID: 10997932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics of antipsychotics: useful for the clinician?
    Bondy B; Spellmann I
    Curr Opin Psychiatry; 2007 Mar; 20(2):126-30. PubMed ID: 17278909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic strategies for the personalization of antipsychotic treatment.
    Kerwin RW; Mancama DT; Arranz MJ
    Expert Rev Mol Diagn; 2001 Sep; 1(3):275-80. PubMed ID: 11901832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of serotonin 2A receptors in the analgesic effect of tramadol in mono-arthritic rats.
    Xie H; Dong ZQ; Ma F; Bauer WR; Wang X; Wu GC
    Brain Res; 2008 May; 1210():76-83. PubMed ID: 18417104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent evidences in the pharmacological mechanisms of the tramadol].
    Mimami K
    Masui; 2005 Nov; 54(11):1224-33. PubMed ID: 16296359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics and forensic toxicology.
    Musshoff F; Stamer UM; Madea B
    Forensic Sci Int; 2010 Dec; 203(1-3):53-62. PubMed ID: 20828952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.